These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 11358939)
1. Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model. Griffin KA; Picken M; Bakris GL; Bidani AK Hypertension; 2001 May; 37(5):1268-72. PubMed ID: 11358939 [TBL] [Abstract][Full Text] [Related]
2. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats. Baylis C; Qiu C; Engels K Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963 [TBL] [Abstract][Full Text] [Related]
3. Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Griffin KA; Picken MM; Bakris GL; Bidani AK Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447 [TBL] [Abstract][Full Text] [Related]
4. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes. Ma G; Allen TJ; Cooper ME; Cao Z Kidney Int; 2004 Sep; 66(3):1090-8. PubMed ID: 15327403 [TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Karam H; Clozel JP; Bruneval P; Gonzalez MF; Ménard J Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345 [TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic interaction between mibefradil and other calcium channel blockers. Matthes J; Huber I; Haaf O; Antepohl W; Striessnig J; Herzig S Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):578-83. PubMed ID: 10882031 [TBL] [Abstract][Full Text] [Related]
7. Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation. Griffin KA; Hacioglu R; Abu-Amarah I; Loutzenhiser R; Williamson GA; Bidani AK Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1136-43. PubMed ID: 14996672 [TBL] [Abstract][Full Text] [Related]
8. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats. Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484 [TBL] [Abstract][Full Text] [Related]
9. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine. Greven J Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707 [TBL] [Abstract][Full Text] [Related]
10. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay. Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. Nakamura Y; Ono H; Frohlich ED Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453 [TBL] [Abstract][Full Text] [Related]
12. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster. Villame J; Massicotte J; Jasmin G; Dumont L Cardiovasc Drugs Ther; 2001 Jan; 15(1):41-8. PubMed ID: 11504162 [TBL] [Abstract][Full Text] [Related]
13. No apparent role for T-type Ca²⁺ channels in renal autoregulation. Frandsen RH; Salomonsson M; Hansen PB; Jensen LJ; Braunstein TH; Holstein-Rathlou NH; Sorensen CM Pflugers Arch; 2016 Apr; 468(4):541-50. PubMed ID: 26658945 [TBL] [Abstract][Full Text] [Related]
14. Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil. Lijnen PJ Cardiovasc Drugs Ther; 2002 May; 16(3):179-80. PubMed ID: 12374893 [No Abstract] [Full Text] [Related]
15. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats. Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553 [TBL] [Abstract][Full Text] [Related]
16. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels. Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade. Ball CJ; Wilson DP; Turner SP; Saint DA; Beltrame JF Hypertension; 2009 Apr; 53(4):654-60. PubMed ID: 19237682 [TBL] [Abstract][Full Text] [Related]
19. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo. Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369 [TBL] [Abstract][Full Text] [Related]